Giovanni Stropoli
Chief Commercial Officer Europe
marketing
Santhera Pharmaceuticals
Switzerland
Biography
Giovanni Stropoli is an experienced commercial manager in the pharmaceutical industry. Up to January 2015, he served as Senior Vice President for the ‘Mid-Sized Countries’ region at lnterMune, a US-based orphan drug corporation recently acquired by F. Hoffmann-La Roche. While at lnterMune, he successfully launched Esbriet® (pirfenidone) in 11 countries. Prior to this, he held several roles within Eisai, a large Japanese multinational corporation, from 2005 to 2011, including Country Manager for Italy, Regional Manager for Mid-Sized Countries and finally Senior Vice President, New Markets in London, UK. He was previously Country Manager for Italy at ALK-Abelló, a Danish market leader in vaccine therapy for allergies and he also covered several sales and marketing positions at Eli Lilly, a US-based corporation, with assignments in Italy, the USA and Spain. Giovanni started his professional career in 1998 as a sales representative for the Italian company, Alfa Wassermann. He holds a degree in veterinary medicine.
Research Interest
veterinary medicine
